bromocriptine has been researched along with cyproheptadine in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (59.52) | 18.7374 |
| 1990's | 14 (33.33) | 18.2507 |
| 2000's | 1 (2.38) | 29.6817 |
| 2010's | 2 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamblin, MW; Jose, PA; Metcalf, MA; Monsma, FJ; Shen, Y; Sibley, DR | 1 |
| Druck, T; Hamblin, MW; Huebner, K; Khan, N; Kohen, R; Lachowicz, JE; Meltzer, HY; Metcalf, MA; Roth, BL; Sibley, DR | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gregorová, I; Marek, J; Matys, Z | 1 |
| Bricaire, H; Ghnassia, JP; Luton, JP | 1 |
| Dent, R; Guyda, H; Tolis, G | 1 |
| Botalla, L; Chiodini, PG; Cremascoli, G; Liuzzi, A; Muller, EE; Oppizzi, G; Silvestrini, F; Verde, G | 1 |
| Kato, Y | 2 |
| Oleĭnik, VA; Rudichenko, VM; Slavnov, VN | 1 |
| Barba Chacón, A; García Osle, M; García Rojas, JF; Mangas Rojas, A; Zamora Madaria, E | 1 |
| Fanghanel, G; Fanghanel, L; Larraza, O; Velasco, F; Velasco, M; Villalobos, M | 1 |
| Atkinson, AB; Beacom, R; Sheridan, B; Whitehead, HM | 1 |
| Hanew, K; Ishii, K; Saitoh, T; Sasaki, A; Saso, S; Sato, S; Shimizu, Y; Sugawara, A; Tazawa, S; Yoshinaga, K | 1 |
| Croughs, RJ; Koppeschaar, HP; McNicol, AM; van't Verlaat, JW | 1 |
| Corenblum, B | 1 |
| Atkinson, AB; Carson, DJ; Hadden, DR; Kennedy, AL; Sheridan, B; Weaver, JA | 1 |
| Besser, GM; Howlett, TA; Rees, LH | 1 |
| Cheban, AK; Luchitskiĭ, EV; Slavnov, VN | 1 |
| Kinouchi, T; Shimizu, N; Takeda, F; Yoshida, H | 1 |
| Croughs, RJ; Koppeschaar, HP; Schwarz, F; Thijssen, JH | 2 |
| Burch, WM | 1 |
| Fujita, T; Hirata, Y; Ikeda, M; Nakashima, H; Tomita, M; Uchihashi, M | 1 |
| Goldfine, ID; Vigneri, R | 1 |
| Krieger, DT | 1 |
| Caraceni, TA; Giovannini, P; Girotti, F; Parati, EA; Pederzoli, M | 1 |
| Weiss, MH | 1 |
| Richkind, M | 1 |
| Bergstrand, CG; Nilsson, KO | 1 |
| Yamaji, T | 1 |
| Bricaire, H; Luton, JP | 1 |
| Alagna, S; Faedda, R; Masala, A; Rovasio, PP; Satta, A | 1 |
| Crapo, L; Miller, JW | 1 |
| Miura, K | 1 |
| Kintzer, PP; Peterson, ME | 1 |
| Komissarenko, IV; Markov, VV; Oleĭnik, VA; Rudichenko, VM; Slavnov, VN | 1 |
| Chik, CL; Cutler, GB; Mercado-Asis, LB; Tracer, HL; Yanovski, JA | 1 |
| Braghiroli, L; De Feo, G; Giacomelli, S; Koppenaal, DW; Ponzianelli, A | 1 |
| Cheng, CY; Giacomelli, S; Palmery, M; Romanelli, L; Silvestrini, B | 1 |
| Casulari, LA; Mello, PA; Naves, LA; Papadia, C; Pereira Neto, A | 1 |
11 review(s) available for bromocriptine and cyproheptadine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Drug therapy of pituitary tumors].
Topics: Bromocriptine; Cushing Syndrome; Cyproheptadine; Female; Humans; Male; Metyrapone; Octreotide; Pituitary Neoplasms; Prolactinoma | 1991 |
Cushing's syndrome.
Topics: Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Alcoholism; Bromocriptine; Circadian Rhythm; Corticotropin-Releasing Hormone; Cushing Syndrome; Cyproheptadine; Depression; Dexamethasone; Female; Gonadotropin-Releasing Hormone; Humans; Hydrocortisone; Insulin; Male; Metyrapone; Mitotane; Pituitary Gland; Potassium; Prognosis; Prolactin; Thyrotropin-Releasing Hormone; Time Factors; Tomography, X-Ray Computed | 1985 |
[Drug and radiotherapy of pituitary tumors].
Topics: Acromegaly; Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Cushing Syndrome; Cyproheptadine; Growth Hormone; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Reserpine; Valproic Acid | 1986 |
Cushing's disease. A review.
Topics: Adenoma; Adolescent; Adrenalectomy; Adult; Animals; Bromocriptine; Child; Combined Modality Therapy; Cushing Syndrome; Cyproheptadine; Female; Humans; Hypophysectomy; Male; Microsurgery; Middle Aged; Pituitary Neoplasms; Prognosis; Radiotherapy; Recurrence; Reserpine; Sella Turcica; Valproic Acid | 1985 |
Pharmacologic therapy of patients with pituitary tumors secreting prolactin, growth hormone and adrenocorticotropin.
Topics: Adrenergic alpha-Antagonists; Adrenocorticotropic Hormone; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cyproheptadine; Ergolines; Estrogens; Female; Galactorrhea; Growth Hormone; Humans; Hypothalamus; Levodopa; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Prolactin | 1980 |
Physiopathology of Cushing's disease.
Topics: Adenoma; Biomechanical Phenomena; Bromocriptine; Circadian Rhythm; Cushing Syndrome; Cyproheptadine; Disease Models, Animal; Forecasting; Glucocorticoids; Humans; In Vitro Techniques; Neurotransmitter Agents; Peptides; Pituitary Gland; Pituitary Hormones, Anterior; Pituitary Neoplasms; Pro-Opiomelanocortin; Protein Precursors | 1983 |
Treatment of Cushing's disease in children.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Aminoglutethimide; Bromocriptine; Child; Cushing Syndrome; Cyproheptadine; Dihydrotestosterone; Female; Humans; Metyrapone; Mitotane; Pituitary Gland; Valproic Acid | 1982 |
The medical treatment of Cushing's syndrome.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Aminoglutethimide; Animals; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dogs; Horses; Humans; Ketoconazole; Metyrapone; Mifepristone; Mitotane; Octreotide; Palliative Care; Pituitary Gland; Radiography; Valproic Acid | 1993 |
[Non-invasive therapy of Cushing's syndrome].
Topics: Aminoglutethimide; Betamethasone; Bromocriptine; Clinical Trials as Topic; Cushing Syndrome; Cyproheptadine; Follow-Up Studies; Humans; Metyrapone | 1994 |
Medical treatment of pituitary-dependent hyperadrenocorticism in dogs.
Topics: Animals; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dog Diseases; Dogs; Drug Administration Schedule; Ketoconazole; Mitotane; Selegiline | 1994 |
4 trial(s) available for bromocriptine and cyproheptadine
| Article | Year |
|---|---|
[Effect of pathogenetic treatment on vasopressin secretion in patients with hypothalamic syndrome].
Topics: Adolescent; Adult; Bromocriptine; Cyproheptadine; Dopamine; Dopamine Antagonists; Humans; Hypothalamic Diseases; Middle Aged; Paraventricular Hypothalamic Nucleus; Serotonin; Supraoptic Nucleus; Vasopressins | 1991 |
[Criteria for the selection of drugs for the pathogenetic treatment of Itsenko-Cushing disease].
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Clinical Trials as Topic; Cushing Syndrome; Cyproheptadine; Female; Follow-Up Studies; Humans; Hydrocortisone; Male; Middle Aged; Pituitary-Adrenal System | 1985 |
Effects of DA agonist in Huntington disease hyperkinesia.
Topics: Adult; Apomorphine; Bromocriptine; Clinical Trials as Topic; Cyproheptadine; Diazepam; Female; Growth Hormone; Humans; Huntington Disease; Lisuride; Male; Middle Aged | 1980 |
Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cyproheptadine; Drug Combinations; Drug Synergism; Female; Humans; Middle Aged; Nelson Syndrome; Time Factors; Valproic Acid | 1997 |
27 other study(ies) available for bromocriptine and cyproheptadine
| Article | Year |
|---|---|
Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Cell Line; Cell Membrane; Cloning, Molecular; Cyclic AMP; Gene Expression; Kidney Tubules, Proximal; Lysergic Acid Diethylamide; Molecular Sequence Data; Oligodeoxyribonucleotides; Polymerase Chain Reaction; Radioligand Assay; Rats; Receptors, Serotonin; Recombinant Proteins; Serotonin; Transfection | 1993 |
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.
Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Antipsychotic Agents; Base Sequence; Brain Chemistry; Cell Line, Transformed; Chlorocebus aethiops; Chromosome Mapping; Chromosomes, Human, Pair 1; Cloning, Molecular; Clozapine; DNA, Complementary; Genes; Humans; Kinetics; Molecular Sequence Data; Open Reading Frames; Protein Conformation; Rats; Receptors, Serotonin; Recombinant Proteins; Sequence Alignment; Sequence Homology, Nucleic Acid; Serotonin Agents; Signal Transduction; Species Specificity | 1996 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cyproheptadine in Cushing's syndrome.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex Function Tests; Adult; Bromocriptine; Cushing Syndrome; Cyproheptadine; Drug Evaluation; Female; Humans; Male; Metyrapone; Stimulation, Chemical | 1977 |
[Medical treatment and Cushing's disease].
Topics: Aminoglutethimide; Bromocriptine; Cushing Syndrome; Cyproheptadine; Humans; Mitotane | 1977 |
Opiates, prolactin, and the dopamine receptor.
Topics: Apomorphine; Bromocriptine; Chlorpromazine; Cyproheptadine; Heroin Dependence; Humans; Kinetics; Levodopa; Methadone; Morphine; Prolactin; Receptors, Dopamine | 1978 |
Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients.
Topics: Acromegaly; Adult; Aged; Bromocriptine; Cyproheptadine; Ergolines; Female; Growth Hormone; Humans; Male; Metergoline; Middle Aged; Phentolamine; Pituitary Gland; Prolactin; Serotonin Antagonists | 1976 |
[Clinical remission in Cushing's disease through treatment with sodium valproate and bromocriptine].
Topics: Bromocriptine; Chronic Disease; Cushing Syndrome; Cyproheptadine; Drug Therapy, Combination; Female; Humans; Middle Aged; Remission Induction; Time Factors; Valproic Acid | 1991 |
Differential response to aminergic stimuli and biological behavior of growth hormone secreting pituitary adenomas.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Bromocriptine; Cyproheptadine; Diazepam; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Thyrotropin-Releasing Hormone | 1990 |
The effect of cyproheptadine and/or bromocriptine on plasma ACTH levels in patients cured of Cushing's disease by bilateral adrenalectomy.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Cushing Syndrome; Cyproheptadine; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Male; Middle Aged; Time Factors | 1990 |
The combination therapy with bromocriptine and cyproheptadine in patients with acromegaly.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Cyproheptadine; Drug Therapy, Combination; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone; Time Factors; Tomography, X-Ray Computed | 1989 |
Bromocriptine-responsive Cushing's disease associated with anterior pituitary corticotroph hyperplasia or normal pituitary gland.
Topics: Adolescent; Adrenocorticotropic Hormone; Bromocriptine; Cushing Syndrome; Cyproheptadine; Humans; Hyperplasia; Male; Pituitary Gland, Anterior; Valproic Acid | 1989 |
[Drug therapy of pituitary neoplasms].
Topics: Adrenocorticotropic Hormone; Bromocriptine; Cyproheptadine; Delayed-Action Preparations; Female; Growth Hormone; Humans; Male; Pituitary Neoplasms; Prolactin; Somatostatin | 1987 |
The medical treatment of the hypersecreting pituitary gland.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Cyproheptadine; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Gland; Pituitary Neoplasms; Prolactin; Valproic Acid | 1985 |
Five cases of cyclical Cushing's syndrome.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Child, Preschool; Creatinine; Cushing Syndrome; Cyproheptadine; Dexamethasone; Female; Humans; Hydrocortisone; Male; Periodicity | 1985 |
Response to neurotransmitter modulating drugs in patients with Cushing's disease.
Topics: Adolescent; Adult; Bromocriptine; Cushing Syndrome; Cyproheptadine; Female; Humans; Hydrocortisone; Male; Middle Aged; Valproic Acid | 1986 |
Effects of bromocriptine and cyproheptadine on basal and corticotropin-releasing factor (CRF)-induced ACTH release in a patient with Nelson's syndrome.
Topics: Adrenocorticotropic Hormone; Adult; Basal Metabolism; beta-Endorphin; Bromocriptine; Corticotropin-Releasing Hormone; Cyproheptadine; Endorphins; Female; Gonadotropin-Releasing Hormone; Humans; Lypressin; Nelson Syndrome; Pituitary Neoplasms; Thyrotropin-Releasing Hormone | 1984 |
Medical and surgical management of functional pituitary tumors.
Topics: Acromegaly; Adrenocorticotropic Hormone; Bromocriptine; Cushing Syndrome; Cyproheptadine; Growth Hormone; Humans; Pituitary Neoplasms; Prolactin | 1981 |
Cushing syndrome in dogs: treatment with bromocriptine and cyproheptadine.
Topics: Adrenocorticotropic Hormone; Animals; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dog Diseases; Dogs; Female; Hydrocortisone; Pituitary Gland | 1981 |
Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease.
Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dexamethasone; Drug Evaluation; Female; Humans; Hydrocortisone; Lypressin; Valproic Acid | 1983 |
[Medical treatment of functioning pituitary adenomas (author's transl)].
Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Cyproheptadine; Dopamine; Female; Humans; Hypotension; Male; Pituitary Neoplasms; Prolactin | 1981 |
[Cushing's syndrome. Medical treatment of adrenal hypercorticism].
Topics: Adrenal Gland Neoplasms; Aminoglutethimide; Androstanols; Bromocriptine; Cushing Syndrome; Cyproheptadine; Dihydrotestosterone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Metyrapone; Mitotane; Nitriles | 1980 |
Prolactin secretion in man following acute and long-term cimetidine administration.
Topics: Adult; Bromocriptine; Cimetidine; Cyproheptadine; Duodenal Ulcer; Female; Guanidines; Humans; Male; Metergoline; Nomifensine; Prolactin; Secretory Rate; Time Factors | 1980 |
[The effect of the one-time and long-term administration of preparations acting on biogenic amine metabolism on the blood level of pressor peptide hormones].
Topics: Adolescent; Adult; Angiotensin II; Biogenic Amines; Blood Pressure; Bromocriptine; Chronic Disease; Cyproheptadine; Drug Evaluation; Female; Humans; Hypertension; Hypothalamic Diseases; Male; Middle Aged; Syndrome; Time Factors; Vasopressins | 1993 |
A sensitive assay for studying dopaminergic activity in cultures of rat pituitary cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cell Count; Cells, Cultured; Cyproheptadine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Drug Evaluation, Preclinical; Female; Haloperidol; Pituitary Gland; Prolactin; Rats; Rats, Wistar; Spiperone | 1997 |
Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cells, Cultured; Cyproheptadine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Lysergic Acid Diethylamide; Pituitary Gland; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine D2 | 1998 |
Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.
Topics: Adenoma; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Cyproheptadine; Dopamine Agonists; Ergolines; Female; Hormone Replacement Therapy; Humans; Magnetic Resonance Imaging; Nelson Syndrome; Pituitary Neoplasms | 2004 |